CN102631677A - 一种预防和/或治疗动脉粥样硬化的药物组合物 - Google Patents

一种预防和/或治疗动脉粥样硬化的药物组合物 Download PDF

Info

Publication number
CN102631677A
CN102631677A CN2012101166255A CN201210116625A CN102631677A CN 102631677 A CN102631677 A CN 102631677A CN 2012101166255 A CN2012101166255 A CN 2012101166255A CN 201210116625 A CN201210116625 A CN 201210116625A CN 102631677 A CN102631677 A CN 102631677A
Authority
CN
China
Prior art keywords
pharmaceutical composition
androgen
estrogen
dht
dihydrotestosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101166255A
Other languages
English (en)
Chinese (zh)
Inventor
李向东
李宁
张华�
刘原伍
任立明
郭英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN2012101166255A priority Critical patent/CN102631677A/zh
Publication of CN102631677A publication Critical patent/CN102631677A/zh
Pending legal-status Critical Current

Links

Images

CN2012101166255A 2012-04-19 2012-04-19 一种预防和/或治疗动脉粥样硬化的药物组合物 Pending CN102631677A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101166255A CN102631677A (zh) 2012-04-19 2012-04-19 一种预防和/或治疗动脉粥样硬化的药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101166255A CN102631677A (zh) 2012-04-19 2012-04-19 一种预防和/或治疗动脉粥样硬化的药物组合物

Publications (1)

Publication Number Publication Date
CN102631677A true CN102631677A (zh) 2012-08-15

Family

ID=46616360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101166255A Pending CN102631677A (zh) 2012-04-19 2012-04-19 一种预防和/或治疗动脉粥样硬化的药物组合物

Country Status (1)

Country Link
CN (1) CN102631677A (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312718A (zh) * 1998-06-11 2001-09-12 内部研究股份有限公司 与脱氢表雄酮或类似物组合的选择性雌激素受体调节剂
CN1400904A (zh) * 2000-01-28 2003-03-05 恩多研究公司 与雌激素联合的选择性雌激素受体调节剂
CN101444519A (zh) * 1993-01-19 2009-06-03 恩多研究公司 脱氢表雄酮的治疗用途和传送系统

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101444519A (zh) * 1993-01-19 2009-06-03 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
CN1312718A (zh) * 1998-06-11 2001-09-12 内部研究股份有限公司 与脱氢表雄酮或类似物组合的选择性雌激素受体调节剂
CN1400904A (zh) * 2000-01-28 2003-03-05 恩多研究公司 与雌激素联合的选择性雌激素受体调节剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIRGIT BRUCK等: "Gender-Specific Differences in the Effects of Testosterone and Estrogen on the Development of Atherosclerosis in Rabbits", 《ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY》 *
JEREMIAH STAMLER等: "Prevention of Coronary Atherosclerosis by Estrogen-Androgen Administration in the Cholesterol-Fed Chick", 《CIRCULATION RESEARCH》 *

Similar Documents

Publication Publication Date Title
Iglesias et al. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options
Schleich et al. Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male
US11160813B2 (en) Combination therapy for nonalcoholic steatohepatitis (NASH) and liver fibrosis
GELLER et al. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol
Eberle et al. Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate
US20080207769A1 (en) Method for treating benign prostatic hyperplasia
Callow et al. The effect of the administration of testosterone propionate on the urinary excretion of compounds allied to the steroid hormones
EP4234015A2 (fr) Procédés de traitement d'une déficience en testostérone
JP2009035559A (ja) 良性前立腺肥大の治療のためのビタミンd3アナログの使用
Landais et al. A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis
Stubbe Østergaard et al. Hay fever and a single intramuscular injection of corticosteroid: a systematic review
US20080262071A1 (en) Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Carter et al. Effect of oral contraceptives on plasma clearance
Casson et al. DHEA administration to humans: panacea or palaver?
CN102631677A (zh) 一种预防和/或治疗动脉粥样硬化的药物组合物
CN103536922B (zh) 酰基辅酶a:胆固醇酰基转移酶‑2抑制剂在抑制肝癌生长中的应用
Wu Hormonal approaches to male contraception: approaching reality
Balasubramanian et al. DHEA: The remedy for andropause
Meriggiola et al. Recent advances in hormonal male contraception
JP2015533150A (ja) 前立腺がんの根治的又は対症的処置における使用のためのホスフェストロール
Liu et al. Androgen therapy in non-gonadal disease
Costa et al. Face-sparing congenital generalized lipodystrophy type 1 associated with nonclassical congenital adrenal hyperplasia
Segre et al. Effects of epinephrine on the production and metabolic clearance of cortisol in normal men and women and in women with idiopathic hirsutism
Huhtaniemi A hormonal contraceptive for men: how close are we?
EP1793818A2 (fr) Pindolol pour le traitement du syndrome et du trouble dysphorique premenstruel

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120815